United States (US) Cancer Biomarkers Market (2025-2031) Outlook | Share, Forecast, Value, Analysis, Companies, Revenue, Industry, Trends, Growth & Size

Market Forecast By Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Thyroid Cancer, Bladder Cancer), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessment, Other Applications) And Competitive Landscape
Product Code: ETC4471682 Publication Date: Jul 2023 Updated Date: Jan 2025 Product Type: Report
Publisher: 6Wresearch No. of Pages: 85 No. of Figures: 45 No. of Tables: 25

Key Highlights of the Report:

  • United States (US) Cancer Biomarkers Market Outlook
  • Market Size of United States (US) Cancer Biomarkers Market, 2024
  • Forecast of United States (US) Cancer Biomarkers Market, 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Revenues & Volume for the Period 2021 - 2031
  • United States (US) Cancer Biomarkers Market Trend Evolution
  • United States (US) Cancer Biomarkers Market Drivers and Challenges
  • United States (US) Cancer Biomarkers Price Trends
  • United States (US) Cancer Biomarkers Porter's Five Forces
  • United States (US) Cancer Biomarkers Industry Life Cycle
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Biomarkers Type for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Protein Biomarkers for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Genetic Biomarkers for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Other Cancer Biomarkers for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Cancer Type for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Breast Cancer for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Lung Cancer for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Colorectal Cancer for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Prostate Cancer for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Melanoma for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Leukemia for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Thyroid Cancer for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Bladder Cancer for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Profiling Technologies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Omics Technologies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Imaging Technologies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Immunoassay for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Bioinformatics for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Cytogenetics for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Diagnostics for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Research & Development for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Prognostics for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Risk Assessment for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Cancer Biomarkers Market Revenues & Volume By Other Applications for the Period 2021 - 2031
  • United States (US) Cancer Biomarkers Import Export Trade Statistics
  • Market Opportunity Assessment By Biomarkers Type
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By Profiling Technologies
  • Market Opportunity Assessment By Application
  • United States (US) Cancer Biomarkers Top Companies Market Share
  • United States (US) Cancer Biomarkers Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Cancer Biomarkers Company Profiles
  • United States (US) Cancer Biomarkers Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cancer Biomarkers Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cancer Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cancer Biomarkers Market - Industry Life Cycle

3.4 United States (US) Cancer Biomarkers Market - Porter's Five Forces

3.5 United States (US) Cancer Biomarkers Market Revenues & Volume Share, By Biomarkers Type, 2021 & 2031F

3.6 United States (US) Cancer Biomarkers Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 United States (US) Cancer Biomarkers Market Revenues & Volume Share, By Profiling Technologies, 2021 & 2031F

3.8 United States (US) Cancer Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F

4 United States (US) Cancer Biomarkers Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Cancer Biomarkers Market Trends

6 United States (US) Cancer Biomarkers Market, By Types

6.1 United States (US) Cancer Biomarkers Market, By Biomarkers Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Cancer Biomarkers Market Revenues & Volume, By Biomarkers Type, 2021 - 2031F

6.1.3 United States (US) Cancer Biomarkers Market Revenues & Volume, By Protein Biomarkers, 2021 - 2031F

6.1.4 United States (US) Cancer Biomarkers Market Revenues & Volume, By Genetic Biomarkers, 2021 - 2031F

6.1.5 United States (US) Cancer Biomarkers Market Revenues & Volume, By Other Cancer Biomarkers, 2021 - 2031F

6.2 United States (US) Cancer Biomarkers Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Cancer Biomarkers Market Revenues & Volume, By Breast Cancer, 2021 - 2031F

6.2.3 United States (US) Cancer Biomarkers Market Revenues & Volume, By Lung Cancer, 2021 - 2031F

6.2.4 United States (US) Cancer Biomarkers Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F

6.2.5 United States (US) Cancer Biomarkers Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F

6.2.6 United States (US) Cancer Biomarkers Market Revenues & Volume, By Melanoma, 2021 - 2031F

6.2.7 United States (US) Cancer Biomarkers Market Revenues & Volume, By Leukemia, 2021 - 2031F

6.2.8 United States (US) Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2021 - 2031F

6.2.9 United States (US) Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2021 - 2031F

6.3 United States (US) Cancer Biomarkers Market, By Profiling Technologies

6.3.1 Overview and Analysis

6.3.2 United States (US) Cancer Biomarkers Market Revenues & Volume, By Omics Technologies, 2021 - 2031F

6.3.3 United States (US) Cancer Biomarkers Market Revenues & Volume, By Imaging Technologies, 2021 - 2031F

6.3.4 United States (US) Cancer Biomarkers Market Revenues & Volume, By Immunoassay, 2021 - 2031F

6.3.5 United States (US) Cancer Biomarkers Market Revenues & Volume, By Bioinformatics, 2021 - 2031F

6.3.6 United States (US) Cancer Biomarkers Market Revenues & Volume, By Cytogenetics, 2021 - 2031F

6.4 United States (US) Cancer Biomarkers Market, By Application

6.4.1 Overview and Analysis

6.4.2 United States (US) Cancer Biomarkers Market Revenues & Volume, By Diagnostics, 2021 - 2031F

6.4.3 United States (US) Cancer Biomarkers Market Revenues & Volume, By Research & Development, 2021 - 2031F

6.4.4 United States (US) Cancer Biomarkers Market Revenues & Volume, By Prognostics, 2021 - 2031F

6.4.5 United States (US) Cancer Biomarkers Market Revenues & Volume, By Risk Assessment, 2021 - 2031F

6.4.6 United States (US) Cancer Biomarkers Market Revenues & Volume, By Other Applications, 2021 - 2031F

7 United States (US) Cancer Biomarkers Market Import-Export Trade Statistics

7.1 United States (US) Cancer Biomarkers Market Export to Major Countries

7.2 United States (US) Cancer Biomarkers Market Imports from Major Countries

8 United States (US) Cancer Biomarkers Market Key Performance Indicators

9 United States (US) Cancer Biomarkers Market - Opportunity Assessment

9.1 United States (US) Cancer Biomarkers Market Opportunity Assessment, By Biomarkers Type, 2021 & 2031F

9.2 United States (US) Cancer Biomarkers Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 United States (US) Cancer Biomarkers Market Opportunity Assessment, By Profiling Technologies, 2021 & 2031F

9.4 United States (US) Cancer Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) Cancer Biomarkers Market - Competitive Landscape

10.1 United States (US) Cancer Biomarkers Market Revenue Share, By Companies, 2024

10.2 United States (US) Cancer Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All